REQUEST A DEMO
Total
USD $0.00
Search more companies

SBAL Na Onkologichni Zabolyavaniya EOOD (Bulgaria)

Main Activities: General Medical and Surgical Hospitals
Full name: Spetsializirana Bolnitsa Za Aktivno Lechenie Na Onkologichni Zabolyavaniya EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Spetsializirana bolnitsa za aktivno lechenie na onkologichni zabolyavaniya (Hospital for active treatment of cancer) operates more than 50 years and offers diagnostics, treatment and rehabilitation. The facility has a capacity of 30 hospital beds.

Headquarters
Zh.k. Mladost 1 Andrey Saharov 22
Sofia; Sofia - city; Postal Code: 1784

Contact Details: Purchase the SBAL Na Onkologichni Zabolyavaniya EOOD report to view the information.

Basic Information
Total Employees:
Purchase the SBAL Na Onkologichni Zabolyavaniya EOOD report to view the information.
Outstanding Shares:
Purchase the SBAL Na Onkologichni Zabolyavaniya EOOD report to view the information.
Registered Capital:
Purchase the SBAL Na Onkologichni Zabolyavaniya EOOD report to view the information.
Financial Auditors:
Purchase the SBAL Na Onkologichni Zabolyavaniya EOOD report to view the information.
Incorporation Date:
February 27, 2001
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after SBAL Na Onkologichni Zabolyavaniya EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
0%
Total operating revenue
-0.21%
Operating profit (EBIT)
19.44%
EBITDA
-30.11%
Net Profit (Loss) for the Period
38.89%
Total assets
-0.77%
Total equity
0.14%
Operating Profit Margin (ROS)
0.04%
Net Profit Margin
0.04%
Return on Equity (ROE)
0.04%
Quick Ratio
-0.25%
Cash Ratio
-0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?